Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis
Objective: Predictors of response to biologics in rheumatoid arthritis (RA) is an important issue in the current era. Rituximab (RTX) has been demonstrated effective and safe in active RA, resistant to traditional or biologic DMARDs. Methods: Fifty-seven patients with active longstanding RA were tre...
Main Authors: | M. Maset, E. Mansutti, M. Fabris, S. Lombardi, M. Saracco, S. Salvin, L. Quartuccio, S. Pellerito, S. De Vita |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2011-06-01
|
Series: | Reumatismo |
Online Access: | http://www.reumatismo.org/index.php/reuma/article/view/439 |
Similar Items
-
Identification of potential autoantigens in anti-CCP-positive and anti-CCP-negative rheumatoid arthritis using citrulline-specific protein arrays
by: Thomas B. G. Poulsen, et al.
Published: (2021-08-01) -
The Association of Anti-CCP and Disease Activity in Rheumatoid Arthritis
by: Raouf Rahim Merza, et al.
Published: (2014-08-01) -
Comparism between Anti-RA33, Anti-CCP antibodies and Rheumatoid Factor in the Diagnosis of Rheumatoid Arthritis in Iraqi Patients
by: Ammar H. Al-Ubaidi, et al.
Published: (2013-04-01) -
The Clinical Application of Anti-CCP in Rheumatoid Arthritis and Other Rheumatic Diseases
by: CT Chou, et al.
Published: (2007-01-01) -
The diagnostic value of the second generation anti-CCP test in rheumatoid arthritis
by: Spasovski Dejan, et al.
Published: (2008-01-01)